Complement Activation by HIV-1–Infected Cells
- 1 February 1997
- journal article
- basic science
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 14 (2) , 102-109
- https://doi.org/10.1097/00042560-199702010-00002
Abstract
To characterize the mechanisms of complement activation by human immunodeficiency virus type 1 (HIV-1)-infected cells, Cl-4 cells stably expressing the envelope glycoproteins of HIV-1 and the parent African green monkey cell line CV-1 were tested for C1q binding and complement activation. While the parent cell line CV-1 only showed a weak spontaneous activation of the alternative pathway, Cl-4 cells additionally triggered the classical pathway of complement activation independent of anti-HIV antibodies by direct C1q binding. Earlier studies had shown different complement activating potential of cells infected with various HIV isolates. Recombinant soluble CD4-induced shedding of gp120 from the surface of HIV-1–infected cells converted a weak activator isolate (MVP-899) into a strong complement activator. The increase in complement activation was paralleled by the concomitant unmasking of a previously hidden gp41 epitope comprising the major complement-activating domain of gp41 (aa. 601-613). Our results strongly suggest that the transmembrane protein gp41 induces the activation of complement on the surface of infected cells as has been described previously for purified HIV-1 virions. Furthermore, we present evidence that the different potential of HIV isolates to activate the complement system on the cell surface is caused by different degrees of spontaneous gp120 shedding by various HIV isolates.Keywords
This publication has 22 references indexed in Scilit:
- Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.The Journal of Experimental Medicine, 1995
- Decay‐accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complementEuropean Journal of Immunology, 1995
- HIV-I and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cellsAIDS, 1993
- CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4Clinical and Experimental Immunology, 1993
- Analysis of Protein Expression and Virus-like Particle Formation in Mammalian Cell Lines Stably Expressing HIV-1 gag and env Gene Products with or without Active HIV ProteinaseVirology, 1993
- Complement Receptor Type 2 Mediates Infection of the Human CD4-Negative Raji B-Cell Line with Opsonized HIVScandinavian Journal of Immunology, 1992
- Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.The Journal of Experimental Medicine, 1991
- Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.The Journal of Experimental Medicine, 1991
- Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937AIDS, 1990
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985